Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

 CORIN_HUMAN             Reviewed;        1042 AA.
Q9Y5Q5; B0ZBE3; Q2TBD2; Q4W5E5; Q4W5G6; Q9UHY2;
27-APR-2001, integrated into UniProtKB/Swiss-Prot.
11-JAN-2011, sequence version 2.
25-OCT-2017, entry version 168.
RecName: Full=Atrial natriuretic peptide-converting enzyme;
EC=3.4.21.-;
AltName: Full=Corin;
AltName: Full=Heart-specific serine proteinase ATC2;
AltName: Full=Pro-ANP-converting enzyme;
AltName: Full=Transmembrane protease serine 10;
Contains:
RecName: Full=Atrial natriuretic peptide-converting enzyme, N-terminal propeptide;
Contains:
RecName: Full=Atrial natriuretic peptide-converting enzyme, activated protease fragment;
Contains:
RecName: Full=Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment;
Contains:
RecName: Full=Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment;
Contains:
RecName: Full=Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment;
Name=CORIN; Synonyms=CRN, TMPRSS10;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
VARIANTS TYR-13 AND ARG-525.
TISSUE=Heart;
PubMed=10329693; DOI=10.1074/jbc.274.21.14926;
Yan W., Sheng N., Seto M., Morser J., Wu Q.;
"Corin, a mosaic transmembrane serine protease encoded by a novel cDNA
from human heart.";
J. Biol. Chem. 274:14926-14935(1999).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
TYR-13 AND ARG-525.
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
NUCLEOTIDE SEQUENCE [MRNA] OF 734-1040.
TISSUE=Heart;
PubMed=11082206; DOI=10.1046/j.1432-1033.2000.01806.x;
Hooper J.D., Scarman A.L., Clarke B.E., Normyle J.F., Antalis T.M.;
"Localization of the mosaic transmembrane serine protease corin to
heart myocytes.";
Eur. J. Biochem. 267:6931-6937(2000).
[5]
FUNCTION, AND MUTAGENESIS OF SER-985.
PubMed=10880574; DOI=10.1073/pnas.150149097;
Yan W., Wu F., Morser J., Wu Q.;
"Corin, a transmembrane cardiac serine protease, acts as a pro-atrial
natriuretic peptide-converting enzyme.";
Proc. Natl. Acad. Sci. U.S.A. 97:8525-8529(2000).
[6]
ACTIVATION, MUTAGENESIS OF ARG-801 AND SER-985, AND BIOPHYSICOCHEMICAL
PROPERTIES.
PubMed=14559895; DOI=10.1074/jbc.M309991200;
Knappe S., Wu F., Masikat M.R., Morser J., Wu Q.;
"Functional analysis of the transmembrane domain and activation
cleavage of human corin: design and characterization of a soluble
corin.";
J. Biol. Chem. 278:52363-52370(2003).
[7]
PROTEOLYTIC PROCESSING, GLYCOSYLATION, AND DISULFIDE BONDS.
PubMed=17660514; DOI=10.1074/jbc.M703687200;
Liao X., Wang W., Chen S., Wu Q.;
"Role of glycosylation in corin zymogen activation.";
J. Biol. Chem. 282:27728-27735(2007).
[8]
SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
PubMed=19751717; DOI=10.1016/j.cca.2009.09.004;
Peleg A., Jaffe A.S., Hasin Y.;
"Enzyme-linked immunoabsorbent assay for detection of human serine
protease corin in blood.";
Clin. Chim. Acta 409:85-89(2009).
[9]
SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, AND MUTAGENESIS OF
ARG-134; ARG-164; ARG-180; ARG-213; ARG-239; ARG-244; ARG-427; ARG-801
AND SER-985.
PubMed=21288900; DOI=10.1074/jbc.M110.185082;
Jiang J., Wu S., Wang W., Chen S., Peng J., Zhang X., Wu Q.;
"Ectodomain shedding and autocleavage of the cardiac membrane protease
corin.";
J. Biol. Chem. 286:10066-10072(2011).
[10]
ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
LOCATION, GLYCOSYLATION, AND MUTAGENESIS OF ASP-26 AND MET-30.
PubMed=21518754; DOI=10.1074/jbc.M110.217570;
Qi X., Jiang J., Zhu M., Wu Q.;
"Human corin isoforms with different cytoplasmic tails that alter cell
surface targeting.";
J. Biol. Chem. 286:20963-20969(2011).
[11]
FUNCTION, INVOLVEMENT IN PEE5, TISSUE SPECIFICITY, AND VARIANTS PEE5
GLU-317 AND GLY-472.
PubMed=22437503; DOI=10.1038/nature10897;
Cui Y., Wang W., Dong N., Lou J., Srinivasan D.K., Cheng W., Huang X.,
Liu M., Fang C., Peng J., Chen S., Wu S., Liu Z., Dong L., Zhou Y.,
Wu Q.;
"Role of corin in trophoblast invasion and uterine spiral artery
remodelling in pregnancy.";
Nature 484:246-250(2012).
[12]
VARIANT ARG-525.
PubMed=17918732; DOI=10.1002/humu.20617;
Guipponi M., Toh M.-Y., Tan J., Park D., Hanson K., Ballana E.,
Kwong D., Cannon P.Z.F., Wu Q., Gout A., Delorenzi M., Speed T.P.,
Smith R.J.H., Dahl H.-H.M., Petersen M., Teasdale R.D., Estivill X.,
Park W.J., Scott H.S.;
"An integrated genetic and functional analysis of the role of type II
transmembrane serine proteases (TMPRSSs) in hearing loss.";
Hum. Mutat. 29:130-141(2008).
-!- FUNCTION: Serine-type endopeptidase involved in atrial natriuretic
peptide hormone (NPPA) processing. Converts through proteolytic
cleavage the non-functional propeptide NPPA into the active
hormone, thereby regulating blood pressure in heart and promoting
natriuresis, diuresis and vasodilation. Proteolytic cleavage of
pro-NPPA also plays a role in female pregnancy by promoting
trophoblast invasion and spiral artery remodeling in uterus. Also
acts as a regulator of sodium reabsorption in kidney. May also
process pro-NPPB the B-type natriuretic peptide.
-!- FUNCTION: Isoform 2: has weaker endopeptidase activity compared to
isoform 1.
-!- ENZYME REGULATION: Inhibited in a dose-dependent manner by non-
specific trypsin-like serine protease inhibitors including
benzamidine.
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=1.28 mM for pyroGlu-Phe-Lys-pNA.HCl
{ECO:0000269|PubMed:14559895};
KM=3.52 mM for pyroGlu-Pro-Arg-pNA.HCl
{ECO:0000269|PubMed:14559895};
KM=2.95 mM for H-D-Pro-Phe-Arg-pNA.2HCl
{ECO:0000269|PubMed:14559895};
KM=1.92 mM for Bz-Ile-Glu-(gamma-OR)-Gly-Arg-pNA.HCl
{ECO:0000269|PubMed:14559895};
KM=16 mM for pyroGlu-Gly-Arg-pNA.HCl
{ECO:0000269|PubMed:14559895};
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19751717,
ECO:0000269|PubMed:21288900, ECO:0000269|PubMed:21518754}; Single-
pass type II membrane protein {ECO:0000269|PubMed:19751717,
ECO:0000269|PubMed:21288900, ECO:0000269|PubMed:21518754}.
Note=May easily detached from the endothelial cell membrane.
-!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane; Single-pass type
II membrane protein. Note=Less efficiently targeted to the cell
membrane compared to isoform 1.
-!- SUBCELLULAR LOCATION: Atrial natriuretic peptide-converting
enzyme, 180 kDa soluble fragment: Secreted. Note=Soluble form
produced following cleavage by ADAM10.
-!- SUBCELLULAR LOCATION: Atrial natriuretic peptide-converting
enzyme, 160 kDa soluble fragment: Secreted. Note=Soluble form
produced following autocatalytic cleavage.
-!- SUBCELLULAR LOCATION: Atrial natriuretic peptide-converting
enzyme, 100 kDa soluble fragment: Secreted. Note=Soluble form
produced following autocatalytic cleavage.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1; Synonyms=E1, hE1;
IsoId=Q9Y5Q5-1; Sequence=Displayed;
Name=2; Synonyms=E1a, hE1a;
IsoId=Q9Y5Q5-2; Sequence=VSP_043952;
-!- TISSUE SPECIFICITY: Highly expressed in heart. Expressed in heart
myocytes. Also expressed in pregnant uterus. Detected in blood, in
plasma as well as in serum (at protein level).
{ECO:0000269|PubMed:10329693, ECO:0000269|PubMed:19751717,
ECO:0000269|PubMed:22437503}.
-!- DOMAIN: The DDNN motif is required for targeting to the cell
membrane and enzyme activation. {ECO:0000269|PubMed:21518754}.
-!- PTM: N-glycosylated; required for processing and activation.
{ECO:0000269|PubMed:17660514, ECO:0000269|PubMed:21518754}.
-!- PTM: Activated through proteolytic processing by a trypsin-like
protease; cleaved into a N-terminal propeptide and an activated
corin protease fragment. Different soluble forms are produced by
cleavage and autocatalytic cleavage: Atrial natriuretic peptide-
converting enzyme, 180 kDa soluble fragment is produced by
cleavage by ADAM10, while 160 kDa and 100 kDa soluble fragments
are produced by autocatalytic cleavage. Cleavage by ADAM10 to
produce soluble 180 kDa soluble fragment takes place after the
transmembrane region and before FZ 1.
-!- PTM: A disulfide bond links the activated corin protease fragment
and the N-terminal propeptide. The disulfide bond also links the
activated corin protease fragment with soluble fragments (100 kDa,
160 kDa and 180 kDa fragments).
-!- DISEASE: Pre-eclampsia/eclampsia 5 (PEE5) [MIM:614595]: A
hypertensive disorder of pregnancy characterized by new
hypertension (blood pressure 140/90 or greater) presenting after
20 weeks' gestation with clinically relevant proteinuria. It
impacts 2 individuals, the mother and her child, both of whom can
be severely affected. Preeclampsia is one of the causes of
maternal mortality and morbidity worldwide.
{ECO:0000269|PubMed:22437503}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- MISCELLANEOUS: Initially named CORIN due to its abundant
expression in the heart. {ECO:0000305|PubMed:10329693}.
-!- SIMILARITY: Belongs to the peptidase S1 family.
{ECO:0000255|PROSITE-ProRule:PRU00274}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF133845; AAD31850.1; -; mRNA.
EMBL; AC092597; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC104646; AAY40991.1; -; Genomic_DNA.
EMBL; AC107068; AAY40917.1; -; Genomic_DNA.
EMBL; EU326305; ACA05911.1; -; Genomic_DNA.
EMBL; BC110451; AAI10452.1; -; mRNA.
EMBL; AF113248; AAF21966.1; -; mRNA.
CCDS; CCDS3477.1; -. [Q9Y5Q5-1]
RefSeq; NP_001265514.1; NM_001278585.1.
RefSeq; NP_006578.2; NM_006587.3. [Q9Y5Q5-1]
UniGene; Hs.518618; -.
UniGene; Hs.604887; -.
ProteinModelPortal; Q9Y5Q5; -.
SMR; Q9Y5Q5; -.
STRING; 9606.ENSP00000273857; -.
MEROPS; S01.019; -.
iPTMnet; Q9Y5Q5; -.
PhosphoSitePlus; Q9Y5Q5; -.
DMDM; 317373348; -.
PaxDb; Q9Y5Q5; -.
PeptideAtlas; Q9Y5Q5; -.
PRIDE; Q9Y5Q5; -.
Ensembl; ENST00000273857; ENSP00000273857; ENSG00000145244. [Q9Y5Q5-1]
GeneID; 10699; -.
KEGG; hsa:10699; -.
UCSC; uc003gxm.5; human. [Q9Y5Q5-1]
CTD; 10699; -.
DisGeNET; 10699; -.
EuPathDB; HostDB:ENSG00000145244.11; -.
GeneCards; CORIN; -.
H-InvDB; HIX0024555; -.
HGNC; HGNC:19012; CORIN.
HPA; HPA070941; -.
MalaCards; CORIN; -.
MIM; 605236; gene.
MIM; 614595; phenotype.
neXtProt; NX_Q9Y5Q5; -.
OpenTargets; ENSG00000145244; -.
PharmGKB; PA134972424; -.
eggNOG; KOG3577; Eukaryota.
eggNOG; KOG3627; Eukaryota.
eggNOG; COG5640; LUCA.
GeneTree; ENSGT00760000118962; -.
HOGENOM; HOG000060148; -.
HOVERGEN; HBG051079; -.
InParanoid; Q9Y5Q5; -.
KO; K09614; -.
OMA; NYLGHRT; -.
OrthoDB; EOG091G0DF7; -.
PhylomeDB; Q9Y5Q5; -.
TreeFam; TF351678; -.
Reactome; R-HSA-5578768; Physiological factors.
ChiTaRS; CORIN; human.
GeneWiki; CORIN; -.
GenomeRNAi; 10699; -.
PRO; PR:Q9Y5Q5; -.
Proteomes; UP000005640; Chromosome 4.
Bgee; ENSG00000145244; -.
CleanEx; HS_CORIN; -.
ExpressionAtlas; Q9Y5Q5; baseline and differential.
Genevisible; Q9Y5Q5; HS.
GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
GO; GO:0009986; C:cell surface; IEA:Ensembl.
GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
GO; GO:0016604; C:nuclear body; IDA:HPA.
GO; GO:0005886; C:plasma membrane; IDA:HPA.
GO; GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB.
GO; GO:0007565; P:female pregnancy; IMP:UniProtKB.
GO; GO:0016486; P:peptide hormone processing; IDA:UniProtKB.
GO; GO:0008217; P:regulation of blood pressure; ISS:UniProtKB.
GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
GO; GO:0035813; P:regulation of renal sodium excretion; ISS:UniProtKB.
GO; GO:0003050; P:regulation of systemic arterial blood pressure by atrial natriuretic peptide; IMP:UniProtKB.
CDD; cd00112; LDLa; 7.
CDD; cd00190; Tryp_SPc; 1.
Gene3D; 1.10.2000.10; -; 2.
InterPro; IPR017052; Corin.
InterPro; IPR020067; Frizzled_dom.
InterPro; IPR036790; Frizzled_dom_sf.
InterPro; IPR036055; LDL_receptor-like_sf.
InterPro; IPR023415; LDLR_class-A_CS.
InterPro; IPR002172; LDrepeatLR_classA_rpt.
InterPro; IPR009003; Peptidase_S1_PA.
InterPro; IPR017448; SRCR-like_dom.
InterPro; IPR036772; SRCR-like_dom_sf.
InterPro; IPR001254; Trypsin_dom.
InterPro; IPR033116; TRYPSIN_SER.
Pfam; PF01392; Fz; 2.
Pfam; PF00057; Ldl_recept_a; 6.
Pfam; PF15494; SRCR_2; 1.
Pfam; PF00089; Trypsin; 1.
PIRSF; PIRSF036376; Corin; 1.
PRINTS; PR00261; LDLRECEPTOR.
SMART; SM00063; FRI; 2.
SMART; SM00192; LDLa; 7.
SMART; SM00202; SR; 1.
SMART; SM00020; Tryp_SPc; 1.
SUPFAM; SSF50494; SSF50494; 1.
SUPFAM; SSF56487; SSF56487; 1.
SUPFAM; SSF57424; SSF57424; 7.
SUPFAM; SSF63501; SSF63501; 2.
PROSITE; PS50038; FZ; 2.
PROSITE; PS01209; LDLRA_1; 6.
PROSITE; PS50068; LDLRA_2; 7.
PROSITE; PS00420; SRCR_1; 1.
PROSITE; PS50240; TRYPSIN_DOM; 1.
PROSITE; PS00135; TRYPSIN_SER; 1.
1: Evidence at protein level;
Alternative splicing; Autocatalytic cleavage; Cell membrane;
Complete proteome; Disulfide bond; Glycoprotein; Hydrolase; Membrane;
Polymorphism; Protease; Reference proteome; Repeat; Secreted;
Serine protease; Signal-anchor; Transmembrane; Transmembrane helix;
Zymogen.
CHAIN 1 1042 Atrial natriuretic peptide-converting
enzyme.
/FTId=PRO_0000088673.
CHAIN 1 801 Atrial natriuretic peptide-converting
enzyme, N-terminal propeptide.
{ECO:0000305}.
/FTId=PRO_0000391765.
CHAIN 165 801 Atrial natriuretic peptide-converting
enzyme, 160 kDa soluble fragment.
{ECO:0000305}.
/FTId=PRO_0000417984.
CHAIN 428 801 Atrial natriuretic peptide-converting
enzyme, 100 kDa soluble fragment.
{ECO:0000305}.
/FTId=PRO_0000417985.
CHAIN ? 801 Atrial natriuretic peptide-converting
enzyme, 180 kDa soluble fragment.
{ECO:0000305}.
/FTId=PRO_0000417986.
CHAIN 802 1042 Atrial natriuretic peptide-converting
enzyme, activated protease fragment.
{ECO:0000305}.
/FTId=PRO_0000391766.
TOPO_DOM 1 45 Cytoplasmic. {ECO:0000255}.
TRANSMEM 46 66 Helical; Signal-anchor for type II
membrane protein. {ECO:0000255}.
TOPO_DOM 67 1042 Extracellular. {ECO:0000255}.
DOMAIN 134 259 FZ 1. {ECO:0000255|PROSITE-
ProRule:PRU00090}.
DOMAIN 268 304 LDL-receptor class A 1.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 305 340 LDL-receptor class A 2.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 341 377 LDL-receptor class A 3.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 378 415 LDL-receptor class A 4.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 450 573 FZ 2. {ECO:0000255|PROSITE-
ProRule:PRU00090}.
DOMAIN 579 614 LDL-receptor class A 5.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 615 653 LDL-receptor class A 6.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 654 689 LDL-receptor class A 7.
{ECO:0000255|PROSITE-ProRule:PRU00124}.
DOMAIN 690 801 SRCR.
DOMAIN 802 1035 Peptidase S1. {ECO:0000255|PROSITE-
ProRule:PRU00274}.
MOTIF 26 29 DDNN motif.
ACT_SITE 843 843 Charge relay system. {ECO:0000250}.
ACT_SITE 892 892 Charge relay system. {ECO:0000250}.
ACT_SITE 985 985 Charge relay system.
SITE 164 165 Cleavage; by autolysis.
SITE 427 428 Cleavage; by autolysis.
SITE 801 802 Cleavage. {ECO:0000305}.
CARBOHYD 80 80 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 104 104 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 135 135 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 141 141 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 231 231 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 245 245 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 251 251 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 305 305 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 320 320 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 376 376 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 413 413 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 446 446 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 451 451 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 469 469 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 567 567 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 651 651 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 697 697 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 761 761 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 1022 1022 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 139 199 {ECO:0000250}.
DISULFID 147 192 {ECO:0000250}.
DISULFID 183 223 {ECO:0000250}.
DISULFID 212 256 {ECO:0000250}.
DISULFID 216 240 {ECO:0000250}.
DISULFID 269 282 {ECO:0000250}.
DISULFID 277 295 {ECO:0000250}.
DISULFID 289 304 {ECO:0000250}.
DISULFID 306 318 {ECO:0000250}.
DISULFID 313 331 {ECO:0000250}.
DISULFID 325 340 {ECO:0000250}.
DISULFID 342 355 {ECO:0000250}.
DISULFID 350 368 {ECO:0000250}.
DISULFID 362 377 {ECO:0000250}.
DISULFID 379 392 {ECO:0000250}.
DISULFID 387 405 {ECO:0000250}.
DISULFID 399 414 {ECO:0000250}.
DISULFID 455 518 {ECO:0000250}.
DISULFID 463 511 {ECO:0000250}.
DISULFID 502 540 {ECO:0000250}.
DISULFID 529 570 {ECO:0000250}.
DISULFID 533 557 {ECO:0000250}.
DISULFID 580 592 {ECO:0000250}.
DISULFID 587 605 {ECO:0000250}.
DISULFID 599 614 {ECO:0000250}.
DISULFID 616 630 {ECO:0000250}.
DISULFID 624 643 {ECO:0000250}.
DISULFID 637 652 {ECO:0000250}.
DISULFID 655 667 {ECO:0000250}.
DISULFID 662 680 {ECO:0000250}.
DISULFID 674 689 {ECO:0000250}.
DISULFID 790 912 Interchain (between N-terminal propeptide
and activated protease fragment chains).
{ECO:0000305|PubMed:17660514}.
DISULFID 828 844 {ECO:0000250}.
DISULFID 926 991 {ECO:0000250}.
DISULFID 955 970 {ECO:0000250}.
DISULFID 981 1010 {ECO:0000250}.
VAR_SEQ 1 29 Missing (in isoform 2). {ECO:0000305}.
/FTId=VSP_043952.
VARIANT 13 13 C -> Y (in dbSNP:rs2289433).
{ECO:0000269|PubMed:10329693,
ECO:0000269|PubMed:15489334}.
/FTId=VAR_038000.
VARIANT 317 317 K -> E (in PEE5; dbSNP:rs387906894).
{ECO:0000269|PubMed:22437503}.
/FTId=VAR_067795.
VARIANT 444 444 D -> G (in dbSNP:rs13105608).
/FTId=VAR_067796.
VARIANT 472 472 S -> G (in PEE5; dbSNP:rs387906895).
{ECO:0000269|PubMed:22437503}.
/FTId=VAR_067797.
VARIANT 525 525 H -> R (in dbSNP:rs11934749).
{ECO:0000269|PubMed:10329693,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:17918732}.
/FTId=VAR_038001.
MUTAGEN 26 26 D->A: Impairs cell membrane targeting;
when associated with A-30.
{ECO:0000269|PubMed:21518754}.
MUTAGEN 30 30 M->A: Impairs cell membrane targeting;
when associated with A-26.
{ECO:0000269|PubMed:21518754}.
MUTAGEN 134 134 R->A: Does not affect autocatalytic
cleavage. {ECO:0000269|PubMed:21288900}.
MUTAGEN 164 164 R->A: Affects autocatalytic cleavage and
production of Atrial natriuretic peptide-
converting enzyme, 160 kDa soluble
fragment. {ECO:0000269|PubMed:21288900}.
MUTAGEN 180 180 R->A: Does not affect autocatalytic
cleavage. {ECO:0000269|PubMed:21288900}.
MUTAGEN 213 213 R->A: Does not affect autocatalytic
cleavage. {ECO:0000269|PubMed:21288900}.
MUTAGEN 239 239 R->A: Does not affect autocatalytic
cleavage. {ECO:0000269|PubMed:21288900}.
MUTAGEN 244 244 R->A: Does not affect autocatalytic
cleavage. {ECO:0000269|PubMed:21288900}.
MUTAGEN 427 427 R->A: Affects autocatalytic cleavage and
production of Atrial natriuretic peptide-
converting enzyme, 100 kDa soluble
fragment. {ECO:0000269|PubMed:21288900}.
MUTAGEN 801 801 R->A: Loss of activity towards NPPA.
{ECO:0000269|PubMed:14559895,
ECO:0000269|PubMed:21288900}.
MUTAGEN 985 985 S->A: Loss of activity towards NPPA.
{ECO:0000269|PubMed:10880574,
ECO:0000269|PubMed:14559895,
ECO:0000269|PubMed:21288900}.
CONFLICT 854 854 W -> R (in Ref. 4; AAF21966).
{ECO:0000305}.
CONFLICT 876 876 K -> R (in Ref. 4; AAF21966).
{ECO:0000305}.
SEQUENCE 1042 AA; 116486 MW; A3F1CB8EBB676F78 CRC64;
MKQSPALAPE ERCRRAGSPK PVLRADDNNM GNGCSQKLAT ANLLRFLLLV LIPCICALVL
LLVILLSYVG TLQKVYFKSN GSEPLVTDGE IQGSDVILTN TIYNQSTVVS TAHPDQHVPA
WTTDASLPGD QSHRNTSACM NITHSQCQML PYHATLTPLL SVVRNMEMEK FLKFFTYLHR
LSCYQHIMLF GCTLAFPECI IDGDDSHGLL PCRSFCEAAK EGCESVLGMV NYSWPDFLRC
SQFRNQTESS NVSRICFSPQ QENGKQLLCG RGENFLCASG ICIPGKLQCN GYNDCDDWSD
EAHCNCSENL FHCHTGKCLN YSLVCDGYDD CGDLSDEQNC DCNPTTEHRC GDGRCIAMEW
VCDGDHDCVD KSDEVNCSCH SQGLVECRNG QCIPSTFQCD GDEDCKDGSD EENCSVIQTS
CQEGDQRCLY NPCLDSCGGS SLCDPNNSLN NCSQCEPITL ELCMNLPYNS TSYPNYFGHR
TQKEASISWE SSLFPALVQT NCYKYLMFFS CTILVPKCDV NTGEHIPPCR ALCEHSKERC
ESVLGIVGLQ WPEDTDCSQF PEENSDNQTC LMPDEYVEEC SPSHFKCRSG QCVLASRRCD
GQADCDDDSD EENCGCKERD LWECPSNKQC LKHTVICDGF PDCPDYMDEK NCSFCQDDEL
ECANHACVSR DLWCDGEADC SDSSDEWDCV TLSINVNSSS FLMVHRAATE HHVCADGWQE
ILSQLACKQM GLGEPSVTKL IQEQEKEPRW LTLHSNWESL NGTTLHELLV NGQSCESRSK
ISLLCTKQDC GRRPAARMNK RILGGRTSRP GRWPWQCSLQ SEPSGHICGC VLIAKKWVLT
VAHCFEGREN AAVWKVVLGI NNLDHPSVFM QTRFVKTIIL HPRYSRAVVD YDISIVELSE
DISETGYVRP VCLPNPEQWL EPDTYCYITG WGHMGNKMPF KLQEGEVRII SLEHCQSYFD
MKTITTRMIC AGYESGTVDS CMGDSGGPLV CEKPGGRWTL FGLTSWGSVC FSKVLGPGVY
SNVSYFVEWI KRQIYIQTFL LN


Related products :

Catalog number Product name Quantity


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur